Steps in the evaluation processNotification of receipt of application - These notices provide advice that a DIR licence application has been received by the OGTR and that a RARMP is in preparation.
Public calls for comment - The Regulator has invited the public to provide comment on a RARMP regarding the identified risk(s) to human health and the environment and the proposed management measures.
Call for comment closed - Comments on these RARMPs have closed, the Regulator is considering submissions and a decision on the licence is imminent.
For more information about DIR applications, please contact the OGTR. DIR applications are available on request (excluding any information that the Regulator has declared to be, or is under consideration as, Confidential Commercial Information) to anyone that requests a copy (section 54 of the Act). A summary of application and, once prepared, the RARMP for each application is available on this website.
|DIR Licence Application Number||Title of Project||Notification of receipt of application||Public calls for comment on RARMP open||Call for comment closed (under consideration by the Regulator)||Is application being assessed as ‘limited and controlled’?|
|DIR 155||Commercial release of canola genetically modified for omega-3 oil content (DHA canola)||02 Jun 2017||No|
|DIR 154||Limited and controlled release of a GM vaccine for chickens, Vaxsafe® ILT||29 Mar 2017||16 May 2017||Yes|
|DIR 153||Limited and controlled release of sorghum genetically modified for grain quality traits||23 Feb 2017||15 May 2017||Yes|
|DIR 152||Limited and controlled release of wheat and barley genetically modified for abiotic stress tolerance and yield improvement||15 Feb 2017||26 Apr 2017||Yes|
|DIR 148||Commercial supply of Dengvaxia, an attenuated GM dengue vaccine||14 Sep 2016||14 Mar 2017||05 May 2017||No|
View the list of DIRs.